{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:19Z","timestamp":1793141839198,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clindermatol.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:08:59Z","timestamp":1697857739000},"page":"62-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Iris melanoma: Review of clinical features, risks, management, and outcomes"],"prefix":"10.1016","volume":"42","author":[{"given":"Elliot","family":"Cherkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly R.","family":"Marous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.10.009_bib0001","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: from diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5858\/2008-132-268-IM","article-title":"Iris melanoma","volume":"132","author":"Henderson","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0003","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaapos.2011.10.012","article-title":"Iris melanoma: features and prognosis in 317 children and adults","volume":"16","author":"Shields","year":"2012","journal-title":"J AAPOS"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004397-199703740-00008","article-title":"Iris melanomas: diagnosis and management","volume":"37","author":"Yap-Veloso","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-620X.122269","article-title":"Review of cystic and solid tumors of the iris","volume":"6","author":"Shields","year":"2013","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0012","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ophtha.2012.09.042","article-title":"Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0007","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ophtha.2017.11.040","article-title":"Iris melanoma outcomes based on the American Joint Committee on Cancer classification (eighth edition) in 432 patients","volume":"125","author":"Shields","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.clindermatol.2023.10.009_bib0008","first-page":"925","article-title":"Iris melanomas in children","volume":"119","author":"Kivel\u00e4","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0009","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0039-6257(81)90073-4","article-title":"The melanoma controversy: a comparison of choroidal, cutaneous, and iris melanomas","volume":"25","author":"Davidorf","year":"1981","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.survophthal.2003.08.001","article-title":"Anterior segment tumors: current concepts and innovations","volume":"48","author":"Marigo","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.1958.00940080207003","article-title":"The prognosis of primary tumors of the iris treated by iridectomy","volume":"60","author":"Rones","year":"1958","journal-title":"AMA Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ICU.0000000000000550","article-title":"Glaucoma secondary to intraocular tumors: mechanisms and management","volume":"30","author":"Camp","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0014","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0161-6420(83)34500-0","article-title":"The differential diagnosis of malignant melanoma of the iris: a clinical study of 200 patients","volume":"90","author":"Shields","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00156993","article-title":"Iris nevi and melanomas: a clinical follow-up study","volume":"82","author":"van Klink","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0016","first-page":"771","article-title":"Primary cysts of the iris","volume":"79","author":"Shields","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0017","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2011.07.059","article-title":"Clinical survey of 3680 iris tumors based on patient age at presentation","volume":"119","author":"Shields","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0018","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-9394(85)90679-8","article-title":"Association between iris color and iris melanocytic lesions","volume":"100","author":"Kliman","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000304885","article-title":"Primary tumours of the iris","volume":"151","author":"Ashton","year":"1966","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0020","first-page":"23","article-title":"Melanoma of the iris: report of 72 cases treated surgically","volume":"6","author":"Arentsen","year":"1975","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0021","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sjopt.2013.06.013","article-title":"Uveal melanoma in children and teenagers","volume":"27","author":"Shields","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0022","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004397-196206000-00008","article-title":"Uveal melanomas in children and adolescents","volume":"2","author":"Apt","year":"1962","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0023","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0039-6257(85)90207-3","article-title":"Iris melanoma: nevus or malignancy?","volume":"29","author":"Kersten","year":"1985","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0024","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1011-1344(01)00168-3","article-title":"Melanin content of cultured human melanocytes and UV-induced cytotoxicity","volume":"61","author":"De Leeuw","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1600-0749.2006.00345.x","article-title":"The physical and chemical properties of eumelanin","volume":"19","author":"Meredith","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/112067219300300402","article-title":"Malignant melanoma of the iris: a 25-year analysis of Danish cases","volume":"3","author":"Jensen","year":"1993","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0420.2007.01011.x","article-title":"Incidence of iris melanoma in western Norway","volume":"86","author":"Krohn","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bjo.85.1.4","article-title":"Iris melanomas: are they more frequent in New Zealand?","volume":"85","author":"Michalova","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0029","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0161-6420(88)33022-8","article-title":"Natural course of melanocytic tumors of the iris","volume":"95","author":"Territo","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ajo.2011.11.004","article-title":"Clinical and ultrasound biomicroscopy features associated with growth in iris melanocytic lesions","volume":"153","author":"Giuliari","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0031","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0059","series-title":"AJCC Cancer Staging Manual","first-page":"805","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2017"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0032","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2012.06.053","article-title":"Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0033","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.17-21838","article-title":"Frequent GNAQ, GNA11, and EIF1AX mutations in iris melanoma","volume":"58","author":"Scholz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0034","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights","volume":"9","author":"Helgadottir","year":"2016","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0035","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1167\/iovs.07-0440","article-title":"The T1799A BRAF mutation is present in iris melanoma","volume":"48","author":"Henriquez","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0036","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bjo.2010.181289","article-title":"Chromosomal aberrations in iris melanomas","volume":"95","author":"Mensink","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0037","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bjo.2004.059535","article-title":"Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours","volume":"89","author":"Conway","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0038","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ophtha.2006.05.042","article-title":"Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0039","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","article-title":"Iris melanoma: risk factors for metastasis in 169 consecutive patients","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","article-title":"Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study","volume":"130","author":"Khan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0041","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9394(02)02241-9","article-title":"Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications","volume":"135","author":"Shields","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0042","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ophtha.2011.09.039","article-title":"Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases","volume":"119","author":"Shah","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0043","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0161-6420(96)30392-8","article-title":"Block excision of tumors of the anterior uvea","volume":"103","author":"Naumann","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0044","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1755-3768.2010.01889.x","article-title":"Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients","volume":"90","author":"Klauber","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjo.85.7.848","article-title":"Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment","volume":"85","author":"Conway","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0046","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.80.2.102","article-title":"Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection","volume":"80","author":"Damato","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0047","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2017.10.009","article-title":"Proton beam therapy for iris melanomas in 107 patients","volume":"125","author":"Thariat","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0048","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.eye.6701361","article-title":"125I plaque brachytherapy for anterior uveal melanomas","volume":"18","author":"Lumbroso-Le Rouic","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0049","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archopht.126.4.578","article-title":"Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy","volume":"126","author":"Bianciotto","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.85.6.666","article-title":"Factors associated with elevated intraocular pressure in eyes with iris melanoma","volume":"85","author":"Shields","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0051","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0002-9394(14)76028-3","article-title":"Iris melanomas","volume":"99","author":"Geisse","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0052","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2214\/ajr.157.6.1950883","article-title":"The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients","volume":"157","author":"Lorigan","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0053","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","article-title":"Survival of patents with metastases from uveal melanoma","volume":"98","author":"Gragoudas","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0054","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaophthalmol.2018.2466","article-title":"Survival rates in patients after treatment for metastasis from uveal melanoma","volume":"136","author":"Lane","year":"2018","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0055","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J","article-title":"Prognosis and treatment of disseminated uveal melanoma","volume":"72","author":"Kath","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0057","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.009_bib0058","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Eng J Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:22:12Z","timestamp":1760034132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23001748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0738081X23001748"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iris melanoma: Review of clinical features, risks, management, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}